Trastuzumab In Combination With Chemotherapy Versus Chemotherapy Alone For Treatment Of HER2-positive Advanced Gastric Or Gastro-Oesophageal Junction Cancer (ToGA): A Phase 3, Open-Label, Randomised Controlled Trial

·2010·DOI

Role in the Field

Abstract

Citations

3,737

Year

2010

PageRank

4.2 / 10

Relative influence (log-scaled)

Trastuzumab In Combination With Chemotherapy Versus Chemotherapy Alone For Treatment Of HER2-positive Advanced Gastric Or Gastro-Oesophageal Junction Cancer (ToGA): A Phase 3, Open-Label, Randomised Controlled Trial | Manumap